Nida Khan in TCS Nashik case: Designation disputed, pregnancy cited for bail, police deploy four teams in ongoing manhunt
Fresnillo (LSE: FRES): Can the world’s largest silver miner hold its record gains as 2026 output dips?
TCS CEO corrects three major Nashik facts: Nida Khan was not HR head, unit not shut, no POSH complaints on record
Read More Pharma Industry News Is Jagsonpal Pharmaceuticals’ asset-light model a blueprint for mid-cap pharma growth in India? Jagsonpal Pharmaceuticals’ asset-light model, zero-debt balance sheet, and 23% ROE show how mid-cap Indian pharma firms can grow without heavy capex. byPallavi MadhirajuJuly 29, 2025